Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
In a recent study using colon expression quantitative trait loci (eQTL) mapping in 40 healthy African American individuals (PMID:25766683), UBA7 was identified as one of several target genes associated with inflammatory bowel disease (IBD), including Crohn disease. This study demonstrated significant enrichment of GWAS variants in colon tissue, implicating UBA7 in the disease biology. However, a complementary case series in a South Asian population did not find a robust association for UBA7, thereby introducing some conflicting genetic evidence (PMID:30568945). No specific pathogenic coding variants for UBA7 have been reported in these studies.
Functionally, UBA7 plays a critical role in the ISGylation pathway—a post‐translational modification process involved in innate immune regulation. Experimental studies have shown that components of this pathway, including UBA7, impact cellular responses to interferon and antiviral defense (PMID:18560560; PMID:19073728). Although the genetic evidence for an association between UBA7 and Crohn disease remains limited, the functional data provide moderate support for its biological relevance in immune processes that could underlie disease pathogenesis. Key take‑home sentence: UBA7 represents a candidate gene for Crohn disease whose involvement in immune regulation merits further investigation to enhance diagnostic precision and therapeutic strategy planning.
Gene–Disease AssociationLimitedUBA7 was implicated based solely on statistical enrichment in colon eQTL data from 40 subjects (PMID:25766683), with limited replication in a South Asian cohort (PMID:30568945) and no supporting segregation data. Genetic EvidenceLimitedGenetic association relies on population-based eQTL mapping without case-level segregation or coding variant reports, limiting the strength of the evidence. Functional EvidenceModerateFunctional assays demonstrate that UBA7 is integral to the ISGylation pathway, a process that modulates interferon responses and innate immunity, which are relevant to IBD pathophysiology (PMID:18560560; PMID:19073728). |